A genome-wide association study reveals evidence of association with sarcoidosis at 6p12.1

S. Hofmann, A. Fischer, A. Till, J. Müller-Quernheim, R. Häsler, A. Franke, K. I. Gäde, H. Schaarschmidt, P. Rosenstiel, A. Nebel, M. Schürmann, M. Nothnagel, S. Schreiber, A. Günther, A. Dubaniewicz, S. Pabst, D. Bumbacea, A. Prasse, A. Grubanovic, P. RottoliE. Bargagli, P. Bresser, V. Poletti, M. Luisetti, V. Vucinic, J. Videnovic-Ivanov


Sarcoidosis is a complex systemic inflammatory disease of unknown aetiology that is influenced by a variety of genetic and environmental factors. To identify further susceptibility loci for sarcoidosis, a genome-wide association study (GWAS) was conducted in 381 patients and 392 control individuals based on Affymetrix 100k GeneChip data. The top 25 single-nucleotide polymorphisms (SNPs) were selected for validation in an independent study panel (1,582 patients versus 1,783 controls). Variant rs10484410 on chromosome 6p12.1 was significantly associated, with a Bonferronicorrected p-value of 2.90?10 -2 in the validation sample and a nominal p-value of 2.64?10 -4 in the GWAS. Extensive fine mapping of the novel locus narrowed down the signal to a region comprising the genes BAG2, C6orf65, KIAA1586, ZNF451 and RAB23. Verification of the sarcoidosis-associated nonsynonymous SNP rs1040461 in a further independent case-control sample and quantitative mRNA expression studies point to the RAB23 gene as the most likely risk factor. RAB23 is proposed to be involved in antibacterial defence processes and regulation of the sonic hedgehog signalling pathway. The identified association of the 6p12.1 locus with sarcoidosis implicates this locus as a further susceptibility factor and RAB23 as a potential signalling component that may open up new perspectives in the pathophysiology of sarcoidosis. Copyright?ERS 2011.
Original languageGerman
JournalEuropean Respiratory Journal
Issue number5
Pages (from-to)1127-1135
Number of pages9
Publication statusPublished - 01.11.2011

Cite this